Mustang Bio Inc (MBIO) stock is down -33% over the last week and has fallen -56% over the last 12 months. The average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives MBIO stock a score of 43 out of a possible 100.
That score is chiefly influenced by a short-term technical score of 15. MBIO’s score also includes a long-term technical score of 23. The fundamental score for MBIO is 90. In addition to the average rating from Wall Street analysts, MBIO stock has a mean target price of $18.00. This means analysts expect the stock to rise 358.02% over the next 12 months.
What’s Happening with MBIO Stock Today
Mustang Bio Inc (MBIO) stock is lower by -14% while the S&P 500 has fallen -0.28% as of 9:58 AM on Tuesday, Apr 30. MBIO has fallen -$0.64 from the previous closing price of $4.57 on volume of 841,385 shares. Over the past year the S&P 500 is higher by 10.82% while MBIO has fallen -56.28%. MBIO lost -$1.14 per share in the over the last 12 months.